World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
102
Citations
48245
World Ranking
661
National Ranking
24

Medicine

D-Index
102
Citations
48768
World Ranking
7547
National Ranking
292

Wim Timens publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Wim Timens sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 699 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Wim Timens D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Wim Timens sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Wim Timens is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans multiple fields within medicine and biomedical sciences, with a strong focus on pulmonary and respiratory medicine, molecular biology, and oncology.

The scientist's main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with a substantial number of publications in these areas. More specifically, their subfields of study cover Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery, and Cancer Research.

The primary research topics addressed in Timens's work involve:

  • Neonatal Respiratory Health Research
  • Lung Cancer Treatments and Mutations
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics

Among recent publications, the following are notable:

  • "Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)", 2020, The Journal of Pathology
  • "An integrated cell atlas of the lung in health and disease", 2023, Nature Medicine
  • "Immune microenvironment composition in non-small cell lung cancer and its association with survival", 2020, Clinical & Translational Immunology
  • "Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank", 2021, Communications Biology
  • "Human lung extracellular matrix hydrogels resemble the stiffness and viscoelasticity of native lung tissue", 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology

Frequent co-authors in Timens's collaborations include:

  • Maarten van den Berge
  • Corry-Anke Brandsma
  • Alen Faiz
  • Janette K. Burgess
  • Don D. Sin

Timens's contributions have appeared regularly in several publication venues, with numerous research articles published in bioRxiv (Cold Spring Harbor Laboratory), Scientific Reports, Lung Cancer, American Journal of Physiology-Lung Cellular and Molecular Physiology, and ERJ Open Research.

Best Publications

  • Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

    I. Hamming;W. Timens;M. L.C. Bulthuis;A. T. Lely

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Angiotensin?converting enzyme 2 (ACE2), SARS?CoV?2 and the pathophysiology of coronavirus disease 2019 (COVID?19)

    Arno R. Bourgonje;Amaal Eman Abdulle;Wim Timens;Jan Luuk Hillebrands

  • The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

    B Abraham;JM Anto;E Barreiro;Ehd Bel

  • Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

    Jonathan Weiss;Martin L. Sos;Danila Seidel;Martin Peifer

  • Management of lung nodules detected by volume CT scanning

    Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten

  • The Pathology of Chronic Obstructive Pulmonary Disease

    James C. Hogg;Wim Timens

  • A cellular census of human lungs identifies novel cell states in health and in asthma.

    Felipe A. Vieira Braga;Gozde Kar;Marijn Berg;Orestes A. Carpaij

  • Acute effects of cigarette smoke on inflammation and oxidative stress: a review

    H van der Vaart;D S Postma;W Timens;N H T ten Hacken

  • Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

    James D McKay;Rayjean J Hung;Younghun Han;Xuchen Zong

  • An integrated cell atlas of the lung in health and disease

    Unknown

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • Ongoing airway inflammation in patients with COPD who do not currently smoke

    S. R. Rutgers;D. S. Postma;N. H. T. Ten Hacken;H. F. Kauffman

  • Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

    Peter S. Hammerman;Martin L. Sos;Alex H. Ramos;Chunxiao Xu

  • The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation

    Brigitte Willemse;Dirkje Postma;Wim Timens;ten Nicolaas Hacken

  • The emerging role of ACE2 in physiology and disease

    Inge Hamming;M. E. Cooper;B. L. Haagmans;N. M. Hooper

  • Cigarette smoke-induced emphysema: A role for the B cell?

    Barry W. A. van der Strate;Dirkje S. Postma;Corry-Anke Brandsma;Barbro N. Melgert

  • Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

    B W M Willemse;N H T ten Hacken;B Rutgers;I G A T Lesman-Leegte

  • Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    Brian D. Hobbs;Kim De Jong;Maxime Lamontagne;Yohan Bossé

  • Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma

    Ke Hao;Yohan Bossé;David C. Nickle;Peter D. Paré

  • Ongoing airway inflammation in patients with COPD who do not currently smoke.

    DS Postma;Nht ten Hacken;HF Kauffman

Frequent Co-Authors

Dirkje S. Postma
Dirkje S. Postma University Medical Center Groningen
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Pieter S. Hiemstra
Pieter S. Hiemstra Leiden University Medical Center
Yohan Bossé
Yohan Bossé Université Laval
Huib A. M. Kerstjens
Huib A. M. Kerstjens University Medical Center Groningen
Gerard H. Koppelman
Gerard H. Koppelman University Medical Center Groningen
Ke Hao
Ke Hao Icahn School of Medicine at Mount Sinai
Marc E. Lenburg
Marc E. Lenburg Boston University
Reinoud Gosens
Reinoud Gosens University of Groningen
Avrum Spira
Avrum Spira Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden your career options. Nursing roles, such as Licensed Practical Nurses (LPNs) and Nurse Practitioners (NPs), often intersect with immunological knowledge in patient care, treatment, and research. If you’re considering nursing programs, some schools are known for being more accessible, and you can find options that are lpn schools easy to get into, helping you fast-track your entry into healthcare.

Similarly, if you want to pursue advanced practice nursing, identifying the easiest np programs to get into can streamline the process. These programs balance accessibility with quality education, which is crucial for a successful transition into specialized immunology-related care.

Those focused on mental health and immunology’s role in neurological conditions may benefit from exploring top psychiatric mental health nurse practitioner programs online. These programs offer strong clinical placements, ensuring practical experience combined with theoretical knowledge.

Cost is often a deciding factor, especially for online education. To help manage expenses, consider the cheapest online pmhnp certificate programs, which provide quality training at a lower cost, making it easier to advance your career without excessive debt.

Best Scientists Citing Wim Timens

Trending Scientists

Recently Published Articles